Jeffrey G. Black insider trades

Open-market stock purchases and sales by Jeffrey G. Black, Chief Financial Officer at Exagen Inc, from SEC Form 4 filings since Nov 12, 2009.

Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Sep 1, 2026XGN Exagen IncSold$149K
Sep 1, 2026XGN Exagen IncBought (not open market)$4.7K
Mar 12, 2026XGN Exagen IncBought (not open market)$237K
Mar 12, 2026XGN Exagen IncBought (not open market)$158K
Feb 27, 2026XGN Exagen IncBought (not open market)$4.6K
Feb 24, 2026XGN Exagen IncSold$5.7K

Companies traded

  • XGN Exagen Inc: 1 buy, 3 sales, last Sep 1, 2026
  • LAB Standard Biotools Inc: 2 buys, last Aug 20, 2024
  • APEN Apollo Endosurgery, Inc: 4 buys, last Apr 4, 2023
  • ATEC Alphatec Holdings, Inc: 2 buys, 6 sales, last Mar 9, 2021
  • VRNM Verenium Corp: 6 buys, last Oct 31, 2013

Get free alerts when Jeffrey G. Black files a new trade →